Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.

Clinical Drug Investigation
A D RinkKarl-Heinz Vestweber

Abstract

Intra-abdominal abscesses are usually polymicrobial and involve a variety of aerobic and anaerobic organisms. Thus, in addition to adequate drainage, empirical coverage with broad-spectrum antimicrobials is central to the management of such abscesses and an understanding of pharmacokinetic properties can be valuable when selecting antimicrobial agents. The present study examined the penetration of the fluoroquinolone antimicrobial moxifloxacin into abdominal abscess fluid in patients with an intra-abdominal abscess. This was a non-randomized, open-label, single-centre trial. Eight patients with CT or ultrasound evidence of a localized intra-abdominal abscess requiring interventional drainage without signs of generalized peritonitis were considered suitable candidates for pharmacokinetic analysis. Each patient received a single dose of moxifloxacin 400 mg by intravenous infusion. Paired samples of blood and abscess fluid were collected over 24 hours for pharmacokinetic analysis. Following intravenous infusion, moxifloxacin penetrated and accumulated in intra-abdominal abscess fluid. The abscess fluid/plasma concentration ratio increased continuously from 0.083 (95% CI 0.047, 0.147) at 2 hours after administration to 1.66 (95% CI...Continue Reading

References

Dec 1, 1992·Current Opinion in Neurology and Neurosurgery
Nov 1, 1991·Annals of Surgery·D M MosdellD E Fry
Dec 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M E FalagasD R Snydman
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·M MüllerH G Eichler
Mar 17, 2001·The Journal of Antimicrobial Chemotherapy·F BarchiesiM A Viviani
Oct 3, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinUNKNOWN Infectious Diseases Society of America
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C-J SoussyP Courvalin
Apr 2, 2004·The Journal of Antimicrobial Chemotherapy·Martin WirtzHelmut Friess
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Alan R NoelAlasdair P Macgowan
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Robert SauermannChristian Joukhadar
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Ellie J C GoldsteinHelen Fernandez
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George A Jacoby
Jul 26, 2006·Pharmacology·Claudia WagnerChristian Joukhadar
Aug 10, 2006·The Journal of Antimicrobial Chemotherapy·H StassK-H Vestweber

❮ Previous
Next ❯

Citations

Mar 26, 2010·Intensive Care Medicine·Mathias W PletzTobias Welte
Oct 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ellie J C GoldsteinJeffrey D Alder
Sep 8, 2009·The Journal of Antimicrobial Chemotherapy·Michael C OberStefanie Swoboda
May 3, 2014·International Journal of Antimicrobial Agents·Hartmut M Lode
Nov 5, 2013·Journal of Women's Health·Elisa Chilet-RosellMa Angeles Pardo
Aug 18, 2009·Expert Review of Anti-infective Therapy·Olaf Burkhardt, Tobias Welte
Jan 17, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yeu-Jun LauPo-Ren Hsueh
May 9, 2009·Journal of Chemotherapy·G WeissUNKNOWN AIDA Study Group
Apr 25, 2012·International Journal of Antimicrobial Agents·Christoph JustingerOtto Kollmar
Jan 23, 2018·The Pediatric Infectious Disease Journal·Stefan WirthUNKNOWN MOXIPEDIA Study Group
Aug 26, 2017·Expert Review of Anti-infective Therapy·Philippe MontraversAlexy Tran Dinh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

© 2021 Meta ULC. All rights reserved